QDEL:NASDAQ
Quidelortho Corp
$10.83
arrow_downward
-1.01%(-0.11) 1D
$10.80
arrow_downward
-0.28% (-0.030)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.94
High
$11.10
Low
$10.68
Mkt. cap
742.67M
Avg. vol.
1.39M
Volume
760.16K
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
Open
$10.94
High
$11.10
Low
$10.68
Mkt. cap
742.67M
Avg. vol.
1.39M
Volume
760.16K
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
QDEL Q2 2026 Earnings: EPS Beat of 374% Highlights Profitability Resilience as Shares Dip 1.21% - Revenue Growth Report
https://www.dars.gov.et/
·
2 months ago
QDEL Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock Declines - Profit Announcement
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com